TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
EOLS

Evolus Inc

Healthcare · Drug Manufacturers - Specialty & Generic

8.00$ +0.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Evolus Inc (EOLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 226 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EOLS
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
81 77 152 172 240 209 257 178 189 233 226
4.0 0.2 73 94 152 128 179 101 112 151 143
4.0 0.2 0.0 93 110 103 146 54 63 87 54
4.0 0.2 93 130 108 146 54 63 87 54
73 11 9.7 15 22 31 48 55
6.4 3.4 1.8 19 11 12 27
5.0 4.7 1.4 2.6
21 21 21 21 21 21 21 21 21 21 21
56 56 56 56 60 55 51 49 47 49 48
69 85 228 87 161 282 176 159 210 227 249
48 63 213 5.3 24 180 58 47 48 63 75
46 60 211 1.2 95 1.3 1.3 1.4 1.7 2.5
0.2 2.9 0.4 1.6 5.8 9.6 6.1 8.9 4.3 9.2 23
17 91 41 71 72 120 122 146
12 -7.1 -76 84 79 -73 82 18 -21 5.5 -23
-47 -67 -76 -123 -213 -376 -423 -497 -559 -609 -661
19 19 24 24 28 34 50 56 57 62 64

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?